Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18982473rdf:typepubmed:Citationlld:pubmed
pubmed-article:18982473lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:18982473lifeskim:mentionsumls-concept:C0019475lld:lifeskim
pubmed-article:18982473lifeskim:mentionsumls-concept:C1335837lld:lifeskim
pubmed-article:18982473lifeskim:mentionsumls-concept:C0497254lld:lifeskim
pubmed-article:18982473lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:18982473lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:18982473lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:18982473lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:18982473pubmed:issue8lld:pubmed
pubmed-article:18982473pubmed:dateCreated2008-11-4lld:pubmed
pubmed-article:18982473pubmed:abstractTextIt remains controversial whether positron emission tomography (PET) with 2-deoxy-2-[F-18]fluoro-D-glucose (F-18-FDG) can differentiate between benign and malignant musculoskeletal tumors. To uncover the mechanism of F-18-FDG accumulations, we analyzed the correlation between the F-18-FDG accumulation and the expression of glucose transporter 1 (Glut-1) and hexokinase II (HK-II) in benign and malignant musculoskeletal tumors.lld:pubmed
pubmed-article:18982473pubmed:languageenglld:pubmed
pubmed-article:18982473pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982473pubmed:citationSubsetIMlld:pubmed
pubmed-article:18982473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982473pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18982473pubmed:statusMEDLINElld:pubmed
pubmed-article:18982473pubmed:monthOctlld:pubmed
pubmed-article:18982473pubmed:issn0914-7187lld:pubmed
pubmed-article:18982473pubmed:authorpubmed-author:MyouiAkiraAlld:pubmed
pubmed-article:18982473pubmed:authorpubmed-author:YoshikawaHide...lld:pubmed
pubmed-article:18982473pubmed:authorpubmed-author:HiguchiIchiro...lld:pubmed
pubmed-article:18982473pubmed:authorpubmed-author:TomitaYasuhik...lld:pubmed
pubmed-article:18982473pubmed:authorpubmed-author:AozasaKatsuyu...lld:pubmed
pubmed-article:18982473pubmed:authorpubmed-author:HatazawaJunJlld:pubmed
pubmed-article:18982473pubmed:authorpubmed-author:UedaTakafumiTlld:pubmed
pubmed-article:18982473pubmed:authorpubmed-author:QiuYingYlld:pubmed
pubmed-article:18982473pubmed:authorpubmed-author:HamadaKenichi...lld:pubmed
pubmed-article:18982473pubmed:authorpubmed-author:ZhangBinglinBlld:pubmed
pubmed-article:18982473pubmed:issnTypePrintlld:pubmed
pubmed-article:18982473pubmed:volume22lld:pubmed
pubmed-article:18982473pubmed:ownerNLMlld:pubmed
pubmed-article:18982473pubmed:authorsCompleteYlld:pubmed
pubmed-article:18982473pubmed:pagination699-705lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:meshHeadingpubmed-meshheading:18982473...lld:pubmed
pubmed-article:18982473pubmed:year2008lld:pubmed
pubmed-article:18982473pubmed:articleTitle18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.lld:pubmed
pubmed-article:18982473pubmed:affiliationDepartment of Orthopedic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.lld:pubmed
pubmed-article:18982473pubmed:publicationTypeJournal Articlelld:pubmed